Omnicell Inc reports results for the quarter ended in December - Earnings Summary

Omnicell

08/02/2024 14:33

* Omnicell Inc  OMCL.OQ  reported quarterly adjusted
earnings of
33 cents​​ per share for the quarter ended in December,
identical to the same quarter last year.  The mean expectation
of nine analysts for the quarter was for earnings of 15 cents
per share. Wall Street expected results to range from 9 cents
to 22 cents per share.
    * Revenue fell 13.1% to $258.85 million from a year ago;
analysts
expected $255.57 million. 
    * Omnicell Inc's reported EPS for the quarter was a loss
of 32
cents​.
    * The company reported a quarterly loss of $14.38 million.
    * Omnicell Inc shares had fallen by 13.7% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "hold"

Wall Street's median 12-month price target for Omnicell Inc is
$39.00 
This summary was machine generated from LSEG data February 8 at
02:33 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.15           0.33           Beat
 Sep. 30 2023      0.47           0.62           Beat
 Jun. 30 2023      0.28           0.57           Beat
 Mar. 31 2023      0.07           0.39           Beat